Chong Kun Dang Signs Co-Promotion Deal with Novo Nordisk Korea for Obesity Drug Wegovy

Chong Kun Dang and Novo Nordisk Korea have signed a co-promotion agreement for Wegovy, an obesity drug that led South Korea’s prescription sales in Q2, aiming to expand the domestic obesity treatment market.